EGFR and lung adenocarcinoma: In the exploration of the correlation between MMP11 and immune response, we found that MMP11 expression in lung adenocarcinoma did not correlate with cytotoxic T-cell level and the clinical benefit of ICB therapy regardless of whether EGFR is mutated or not.